Holliston, MA 12/3/07 and 12/14/07; Washington, DC 12/12/07—Harvard Bioscience has rejected an acquisition offer from Skystone Advisors. On December 12, Skystone, which holds 15.4% of Harvard Bioscience’s stock, made an offer to acquire the company and take it private. In a letter to the Harvard Bioscience Board, Skystone stated it would acquire all the outstanding […]
An article in the November 15, 2007, issue of IBO discussed increased concerns about food imports, particularly from China. On December 11, the US and China announced a formal agreement to improve food safety. The agreement applies to four products categories: “low-acid canned products or acidified food”; “pet food/pet treats of plant origin or animal […]
Billerica, MA 12/3/07—Bruker BioSciences has entered into a definitive agreement to acquire sister company Bruker BioSpin in a transaction valued at $914 million. Bruker BioSciences will offer $388 million in cash and 57.5 million shares, which are valued at $528 million according to the 10-day average closing price as of November 28. As a result […]
Although the safety of Chinese food exports to the US has garnered the most attention this year, drug safety has also been high on the agenda of both countries. The prominence of these issues culminated in the countries signing two memoranda of agreement on December 11: one focused on food safety (see page 11) and […]
Kyoto, Japan 11/22/07—-Chromatography supply company YMC has purchase Cellular Process Chemistry GmbH (CPC) for an undisclosed sum. Founded in 1999 and based in Mainz, Germany, CPC produces plate-based microreactor systems for fine chemical synthesis.
Pickering Laboratories, a producer of instruments and reagents for post-column analysis, demonstrates that one of the ways to develop a “killer app” is by having a major standards body mandate a testing method that includes its products. The company, located in San Jose, California, was founded by Michael Pickering in 1984. Post-column analysis takes place […]
Radleys appointed Interchim its exclusive German distributor. Sloning Biotechnology named Microsynth the exclusive distributor of its gene synthesis service and product family of mutant libraries in Switzerland. Sloning Biotechnology selected Research & Innovation as its exclusive Japanese distributor. PNA Inventor Group granted Link Technologies a license to manufacture and sell monomers for peptide nucleic acid […]
Third quarter 2007 IBO Life Science Index sales gained 12.4% to $2,098 million, compared to 8.5% in the same period last year. While favorable currency transactions contributed to overall Index growth, organic revenues sustained significant increases. Operating profit for the Index jumped 29.7% to $311 million and operating margin gained 200 basis points to 14.8% […]
UK-based Analysco is now distributing New Era Enterprises’ NMR sample tubes and accessories. In August, Oxford Instruments acquired VeriCold Technologies GmbH, a manufacturer of pulse tube refrigerators, for an initial payment of £2.0 million ($4.0 million) and an additional £3.7 million ($7.3 million) payable over two years based on growth targets. Varian will comarket and […]
A worldwide shortage of helium is driving prices of the element higher, forcing helium users in many industries to adapt. Demand for helium has been boosted by a wide array of scientific uses, increasing by 80% over the last 20 years in the US and rising by more than 20% annually in developing economies. Because […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
